These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 32138882)

  • 1. Treatment of the Connective Tissue Disease-Related Interstitial Lung Diseases: A Narrative Review.
    Gao Y; Moua T
    Mayo Clin Proc; 2020 Mar; 95(3):554-573. PubMed ID: 32138882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New treatment paradigms for connective tissue disease-associated interstitial lung disease.
    Kouranos V; Miranda G; Corte TJ; Renzoni EA
    Curr Opin Pulm Med; 2018 Sep; 24(5):453-460. PubMed ID: 30020142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of interstitial lung disease associated with connective tissue disease.
    Mathai SC; Danoff SK
    BMJ; 2016 Feb; 352():h6819. PubMed ID: 26912511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interstitial lung disease in rheumatic diseases - new therapeutic approaches].
    Jakubczyc A; Neurohr C
    Dtsch Med Wochenschr; 2020 Apr; 145(7):470-473. PubMed ID: 32236928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Connective Tissue Disease-Associated Interstitial Lung Disease.
    Kawano-Dourado L; Lee JS
    Clin Chest Med; 2021 Jun; 42(2):295-310. PubMed ID: 34024405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?
    de Lauretis A; Veeraraghavan S; Renzoni E
    Chron Respir Dis; 2011; 8(1):53-82. PubMed ID: 21339375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recommendations for the diagnosis and treatment of connective tissue disease-associated interstitial lung disease in China].
    Zou QH; Lu YW; Zhou JG; Liu XX; Li MT; Zhao Y
    Zhonghua Nei Ke Za Zhi; 2022 Nov; 61(11):1217-1223. PubMed ID: 36323562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Therapeutic Approaches in Connective Tissue Disease-Associated Interstitial Lung Disease.
    Mulcaire-Jones E; Pugashetti JV; Oldham JM; Khanna D
    Semin Respir Crit Care Med; 2024 Jun; 45(3):435-448. PubMed ID: 38740369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and treatment of connective tissue disease-associated interstitial lung disease.
    Vij R; Strek ME
    Chest; 2013 Mar; 143(3):814-824. PubMed ID: 23460159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interstitial lung disease in connective tissue disorders].
    Mouthon L; Berezné A; Brauner M; Valeyre D; Guillevin L
    Rev Pneumol Clin; 2005 Jun; 61(3):211-9. PubMed ID: 16142195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interstitial lung disease in connective tissue disorders.
    Fischer A; du Bois R
    Lancet; 2012 Aug; 380(9842):689-98. PubMed ID: 22901890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interstitial lung disease in the connective tissue diseases.
    Antin-Ozerkis D; Rubinowitz A; Evans J; Homer RJ; Matthay RA
    Clin Chest Med; 2012 Mar; 33(1):123-49. PubMed ID: 22365251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current and Emerging Drug Therapies for Connective Tissue Disease-Interstitial Lung Disease (CTD-ILD).
    Jee AS; Corte TJ
    Drugs; 2019 Sep; 79(14):1511-1528. PubMed ID: 31399860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Connective Tissue Disease Associated Interstitial Lung Disease.
    Matson SM; Demoruelle MK
    Rheum Dis Clin North Am; 2024 Aug; 50(3):423-438. PubMed ID: 38942578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of connective tissue disease-associated interstitial lung disease.
    Chartrand S; Fischer A
    Rheum Dis Clin North Am; 2015 May; 41(2):279-94. PubMed ID: 25836643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study.
    Cao M; Sheng J; Qiu X; Wang D; Wang D; Wang Y; Xiao Y; Cai H
    BMC Pulm Med; 2019 Nov; 19(1):215. PubMed ID: 31727051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and outcome of acute exacerbation in connective tissue disease-associated interstitial lung disease: A single-center study from India.
    Singh P; Thakur B; Mohapatra AK; Padhan P
    Int J Rheum Dis; 2019 Sep; 22(9):1741-1745. PubMed ID: 31328423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of connective tissue diseases associated interstitial lung disease: a review of the published literature.
    Wallace B; Vummidi D; Khanna D
    Curr Opin Rheumatol; 2016 May; 28(3):236-45. PubMed ID: 27027811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting CD20 in the treatment of interstitial lung diseases related to connective tissue diseases: A systematic review.
    Bellan M; Patrucco F; Barone-Adesi F; Gavelli F; Castello LM; Nerviani A; Andreoli L; Cavagna L; Pirisi M; Sainaghi PP
    Autoimmun Rev; 2020 Feb; 19(2):102453. PubMed ID: 31838163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of connective tissue disease-associated interstitial lung disease: the pulmonologist's point of view.
    Koo SM; Uh ST
    Korean J Intern Med; 2017 Jul; 32(4):600-610. PubMed ID: 28704913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.